Insulet
PODD
591 hedge funds and large institutions have $15.3B invested in Insulet in 2023 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 207 increasing their positions, 194 reducing their positions, and 72 closing their positions.
99% more first-time investments, than exits
New positions opened: 143 | Existing positions closed: 72
37% more capital invested
Capital invested by funds: $11.1B → $15.3B (+$4.16B)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
12% more funds holding
Funds holding: 528 → 591 (+63)
1.13% more ownership
Funds ownership: 99.95% → 101.08% (+1.1%)
7% more repeat investments, than reductions
Existing positions increased: 207 | Existing positions reduced: 194
31% less call options, than puts
Call options by funds: $198M | Put options by funds: $286M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$267M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$208M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$79.1M |
| 4 |
SPC
Slate Path Capital
New York
|
+$76.3M |
| 5 |
Goldman Sachs
New York
|
+$54.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
D1 Capital Partners
New York
|
-$140M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$121M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$82.2M |
| 4 |
ESCM
Echo Street Capital Management
New York
|
-$72.7M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$66.1M |
PODD Hedge Fund Activity: Q4 2023 in Review
591 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2023, worth a combined $15.3B — up 37% from $11.1B a quarter earlier.
Buyers outnumbered sellers: 143 funds opened new PODD positions and 72 closed out — a net gain of 71 holders — while 207 added to existing stakes and 194 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $267M. The largest seller was D1 Capital Partners, cutting an estimated $140M.
- 591 institutional investors held Insulet (PODD) as of Q4 2023, up from 528 in Q3 2023.
- Funds reported $15.3B of Insulet stock for Q4 2023, up 37% quarter-over-quarter.
- 143 funds opened new Insulet positions in Q4 2023 and 72 closed out, a net change of +71 holders.
- The largest Insulet buyer in Q4 2023 was Capital Research Global Investors, an estimated $267M added.
- The largest Insulet seller in Q4 2023 was D1 Capital Partners, an estimated $140M sold.
Based on aggregated 13F filings for Q4 2023.